Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

De novo design of allosteric proteins that sense and respond to small molecules

Award Number: DP2GM170825
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2031

Group Awards By:

View Award Description

De novo design of allosteric proteins that sense and respond to small molecules - Project Summary: This proposal aims to design allosteric proteins driven by binding of small molecules. The deep-learning revolution has enabled facile generation of “static” binders—proteins that passively bind to peptides, proteins, or small molecules. Static binders are useful for a variety of applications (e.g., inhibitors or antidotes), but most natural proteins have more complex functions that extend beyond passive binding. We therefore aim to design “active” proteins that change shape upon binding a ligand. Such allosteric proteins would enable novel, programmable control of signaling events at the nanoscale. Through rounds of computation and experiment, we will uncover the design principles of small-molecule-induced allosteric “communication at a distance” that underpins much of biology, especially in proteins critical for cell signaling and gene regulation. Having established a repertoire of de novo helical bundles that bind to a variety of small-molecule drugs and metabolites, we now aim to pick apart the rules of how to design allostery from scratch. Designed ligand- binding bundles will be connected through the design of frustrated linkers, as well as a more bioinspired approach that mimics signaling mechanisms of G-protein coupled receptors (GPCRs). We will test these designs for cooperative binding and uncover the sequence-structure relationships that give a quantitative understanding of allostery—such that it can be predicted and engineered in a rational way. By testing hypotheses gleaned from natural signaling proteins, we should learn the rules that govern their function, potentially leading to more sophisticated ways to drug them with fewer side effects. More concretely, success would establish fully synthetic, fit-for-purpose “GPCR-like” systems for novel programmable and small- molecule-inducible functions. This accomplishment could potentially revolutionize the approach to targeted therapies by enabling precise drug-delivery mechanisms based on the unique metabolic environments of specific tissues, minimizing off-target effects and improving therapeutic outcomes. By accurately programming allostery, we could also create biosensors from scratch to any small molecule of interest, illuminating this difficult-to-study yet vitally important signaling axis of biology. Thus, we aim to establish a pipeline to generate genetically encodable biosensors that respond to synthetic drugs or natural metabolites at appropriate dynamic ranges to study their mechanisms of action in cells in real time. This research is broadly impactful across disparate fields such as metabolic engineering, biosensing, drug delivery, cell signaling, and neuroscience. It promises to deepen our understanding of protein–ligand interactions, refine the rules of allosteric communication, and pave the way for new therapeutic strategies that leverage distinct metabolic environments associated with disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $845,500 )
2026	2026	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Trans-NIH Research Support	000	1	8/25/2026	NEW	$845,500
														Subtotal = $845,500

Grand Total All Awards = $845,500

Top

All Categories

About

Search

Reports

Data Submission

Award Information

De novo design of allosteric proteins that sense and respond to small molecules

Award Number: DP2GM170825

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer